Evaluation of the interferon-γ release assay in healthcare workers

  • A. Nienhaus
  • A. Schablon
  • C. Le Bâcle
  • B. Siano
  • R. Diel
Original Article



An in vitro test for the diagnosis of latent TB-infection (LTBI) is now available that has the potential to replace the tuberculin skin test (TST). The new test measures the cell-mediated immune response to TB antigens. Little experience is currently available on the performance of the IGRA when testing HCW for LTBI. Therefore the aim of the study was to compare the IGRA with the TST in testing HCW for LTBI.


The medical staffs of three hospitals were simultaneously tested with TST (RT23) and IGRA (QFT). The study comprises 261 HCW, all exposed to active TB-patients. Information on gender, age, workplace, BCG vaccination and history of both TB and TST were collected using a standardised questionnaire.


The TST was positive in 24.1% and the IGRA in 9.6% of the participants. Agreement between the tests was low in HCW with a BCG-vaccination. A history of an earlier TST was a risk factor for a positive TST but not for a positive IGRA. Out of 48 results positive in the TST but negative in the IGRA 97.8% might be explained by BCG vaccination or an earlier TST. A positive association between age and LTBI was observed for the IGRA but not for the TST results. Out of 25 positive results in the IGRA only 60% were recognized by the TST, too. The HCW with a positive IGRA and a negative TST had the same age (mean 49.1) as the HCW positive in both tests (mean 50.9), which was higher than the age of those negative in both tests (mean 38.8).


The data indicate that the IGRA should replace the TST in serial testing of HCW in high income, low incidence countries. The recommendations to use the IGRA in order to verify a positive TST only should be reconsidered.


Latent TB-infection Healthcare worker Tuberculin skin test Interferon-γ release assay 



We thank Ms G. Beckmann, Ms S. Nausester, and Ms. R. Sternfeldt for the medical examinations and the data collection. The study was fully paid for by the Institution for Statutory Accident Insurance and Prevention in the Health and Welfare Services. The authors do not have any competing interests.


  1. Andersen P, Munk ME, Pollock JM, Doherty TM (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356(9235):1099–1104PubMedCrossRefGoogle Scholar
  2. ATS —American Thoracic Society (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161(4 Pt 2):S221–S247Google Scholar
  3. BTS —Joint Tuberculosis Committee of the British Thoracic Society (2000) Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Thorax 55:887–901CrossRefGoogle Scholar
  4. CDC (2005) Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC. MMWR 54:1–37Google Scholar
  5. Diel R, Ernst M, Doscher G, Visuri-Karbe L, Greinert U, Niemann S, Nienhaus A, Lange C (2006a) Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test. Eur Respir J 28(1):16–23PubMedCrossRefGoogle Scholar
  6. Diel R, Nienhaus A, Lange C, Schaberg T (2006b) Cost-optimisation of screening for latent tuberculosis in close contacts. Eur Respir J 28(1):35–44PubMedCrossRefGoogle Scholar
  7. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T (2006) Screening for tuberculosis infection using whole-blood interferon-γ and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 27(5): 442–448PubMedCrossRefGoogle Scholar
  8. Hosmer D, Lemeshow S (2000) Applied logistic regression. Wiley, New YorkGoogle Scholar
  9. Lange C, Schaberg T, Diel R, Greinert U (2006) Current concepts in the diagnosis of tuberkulosis. Deutsch Med Wochenschr 131:341–347CrossRefGoogle Scholar
  10. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK (1996) Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 178(5):1274–1282PubMedGoogle Scholar
  11. Mazurek GH, Hereb J, Lobue P, Iademarco MF, Metchock B, Vernon A (2005) Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 54(RR-15):49–55PubMedGoogle Scholar
  12. Menzies D, Pai M, Comstock G (2007) Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146:340–354PubMedGoogle Scholar
  13. Menzies D (2000) What does tuberculin reactivity after Bacille Calmette–Guerin vaccination tell us? Clin infect Dis 31(Suppl 3):S71–74PubMedCrossRefGoogle Scholar
  14. Nahid P, Pai M, Hopewell PC (2006) Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc 3:103–110PubMedCrossRefGoogle Scholar
  15. NICE —National Institute for Health and Clinical Excellence (2006) Clinical Guideline 33. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. NICE, London, UK.
  16. Pai M (2005) Alternatives to the tuberculin skin test: interferon-γ assays in the diagnosis of Mycobacterium tuberculosis infection. Indian J Med Microbiol 23(3): 151–158PubMedCrossRefGoogle Scholar
  17. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta D, Narang P, Daley C, Granich R, Mazurek G, Reingold A, Riley L, Colford J (2005) Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 293:2746–2755PubMedCrossRefGoogle Scholar
  18. Pai M, Kalantri S, Dheda K (2006a) New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis. Expert Rev Mol Diagn 6(3):413–422PubMedCrossRefGoogle Scholar
  19. Pai M, Joshi R, Dogra S, Mendriatta D, Narang P, Kalantri S, Reingold A, Colford J, Riley L, Menzies D (2006b) Serial testing of health care workers for tuberculosis using interferon-γ assay. AJRCCM 174(3):349–355Google Scholar
  20. RKI —Robert Koch-Institut (2006) Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2004 (Report of the Epidemiology of Tuberculosis in Germany 2004), BerlinGoogle Scholar
  21. Singh D, Sutton C, Woodcock A (2001) Repeat tuberculin testing in BCG-vaccinated subjects in the United Kingdom. The booster effect varies with the time of reading. Am J Respir Crit Care Med 164(6):962–964PubMedGoogle Scholar
  22. Stop TB Partnership, WHO (2006) The Global Plan to Stop TB 2006–2015. WHO Geneva, SwitzerlandGoogle Scholar
  23. Von Pirquet C (1909) Frequency of tuberculosis in children JAMA LII (9)Google Scholar
  24. WHO (2005) Global tuberculosis control. Surveillance, planning, financing. WHO Report 2005, Geneva, Switzerland, pp 1–247Google Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • A. Nienhaus
    • 1
  • A. Schablon
    • 2
  • C. Le Bâcle
    • 3
  • B. Siano
    • 3
  • R. Diel
    • 4
  1. 1.Department of Occupational Health ResearchInstitution for Statutory Accident Insurance and Prevention in the Health and Welfare ServicesHamburgGermany
  2. 2.Faculty of Life sciencesHamburg University of Applied SciencesHamburgGermany
  3. 3.Institut National de Recherche et de SécuritéParisFrance
  4. 4.School of Public HealthUniversity of DüsseldorfDusseldorfGermany

Personalised recommendations